關鍵數據
46.240今開
46.298最高
7.31M成交量
虧損本益比TTM
虧損本益比動
--股利TTM
4.07%換手率
44.290昨收
42.300最低
229.20M成交額
虧損本益比靜
18.90市淨率
0.00%股息率 TTM
-16.47%ROA
104.32052週最高
1.18量比
-746.33M淨利潤
179.40M總股本
-1.7110每股盈餘TTM
--Beta
-81.58%ROE
41.73052週最低
9.03%振幅
64.45%毛利率
7.87B總市值
-6.72回報/風險
4.02%風險率
操作建議
Tempus AI Inc當前公司基本面數據相對穩定,增長潛力很大。當前估值合理,在生物技術與醫療研究行業排名68/385位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為68.37。中期看,股價處於下降通道。近一個月,市場表現非常差,但基本面評分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。
壓力支撐

由於公司未披露,未能獲取相關數據
Tempus AI Inc新聞
即將為您帶來更多新聞,敬請期待。 。 。
收益預測
Ionis Pharmaceuticals Inc
IONS
26
技術指標
財務指標
每股收益

由於公司未披露,未能獲取相關數據
營業總收入

由於公司未披露,未能獲取相關數據
Tempus AI Inc簡介
Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
公司代碼TEM
公司Tempus AI Inc
CEOLefkofsky (Eric P)
網址https://investors.tempus.com/
公司股東
常見問題
Tempus AI Inc(TEM)的當前股價是多少?
Tempus AI Inc(TEM)的當前股價是 43.87。
Tempus AI Inc股票的52週最高點是多少?
Tempus AI Inc股票的52週最高點是104.32。
Tempus AI Inc股票的52週最低點是多少?
Tempus AI Inc股票的52週最低點是41.73。
現在Tempus AI Inc(TEM)的股票是買入、持有還是賣出?
根據分析師評級,Tempus AI Inc(TEM)的總體評級為買入,目標價格為68.37。
Tempus AI Inc(TEM)股票的每股收益(EPS TTM)是多少
Tempus AI Inc(TEM)股票的每股收益(EPS TTM)是-1.41。